Jake Chanin
Cardiovascular Disease · Denver, CONPI 1336460872
Payments from drug & device makers
Across 876 payments — averaging $669.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$364K
- Abbott$179K
- Medtronic$19K
- Abiomed$12K
- Boston Scientific$7K
- Philips North America LLC$968
- plus $4K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 185 | $364,014 |
| Abbott | 291 | $179,047 |
| Medtronic(2 entities) | 70 | $18,915 |
| Abiomed | 115 | $11,726 |
| Boston Scientific | 105 | $7,307 |
| Philips North America LLC | 29 | $968 |
| Medical Device Business Services, Inc. | 7 | $887 |
| Shockwave Medical, Inc | 14 | $759 |
| Penumbra, Inc. | 5 | $556 |
| Livanova USA, Inc. | 6 | $345 |
| W. L. Gore & Associates, Inc. | 5 | $336 |
| Inari Medical, Inc. | 3 | $306 |
| Heartflow, Inc. | 8 | $185 |
| Terumo Medical Corporation | 2 | $136 |
| Cardiva Medical, Inc. | 6 | $116 |
| Cardiovascular Systems Inc. | 2 | $85 |
| Pfizer | 3 | $84 |
| Johnson & Johnson | 3 | $74 |
| Amgen | 3 | $61 |
| E.r. Squibb & Sons, L.L.C. | 2 | $44 |
| Merck | 2 | $43 |
| Baylis Medical Company Inc | 2 | $34 |
| AstraZeneca | 1 | $28 |
| Boehringer Ingelheim | 1 | $26 |
| Cordis US CORP. | 1 | $24 |
| Novartis | 1 | $23 |
| Corcym Inc | 1 | $23 |
| Cvrx, Inc. | 1 | $22 |
| Scpharmaceuticals Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
How this compares
$586,210 in reported general payments places this provider in the 95th percentile of 276 cardiovascular disease providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Denver
- Nampalli VijayDenver$711K
- Andrew FreemanDenver$454K
- Mori KrantzDenver$174K
- Sameer MehtaDenver$107K
- Paul JurgensDenver$81K
- Michael BristowDenver$56K
- Sam RougasDenver$44K
- John RumsfeldDenver$24K
- Fady IskanderDenver$16K
- Gary LuckasenFort Collins$11M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.